News and insights into the #2 pharma/medtech market - China

Greg B. Scott founded ChinaBio® in 2007 to help western life science companies achieve success in China. ChinaBio® is a consulting and advisory firm based in Shanghai that has helped over 100 U.S., European and APAC companies seeking partnerships, acquisitions, novel ... more

ALL CONTRIBUTIONS

Week In Review: Hansoh Signs $1.5 Billion Cross-Border Deal For AI-Drug Discovery With Atomwise
China's Hansoh Pharma formed an AI-based small molecule drug discovery collaboration worth up to $1.5 billion with Atomwise of San Francisco.
Read
Week In Review: PAG Pays $540 Million For 58% Stake In Hisun BioRay, A China Biotech
PAG, a Hong Kong PE firm, will pay $540 million to acquire a 58% stake in Hisun BioRay, a China biologics company developing autoimmune and oncology drugs.
Read
Week In Review: HiFiBiO Raises $67 Million For Immune Modulator Portfolio
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
Read
Week In Review: Biotheus Acquires China Rights To Three Bi-specifics In $142 Million Deal
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
Read
Week In Review: Chipscreen Gains 367% Following $148 Million Shanghai STAR IPO
China's Chipscreen Bio traded 367% higher following its $148 million IPO on the Shanghai STAR exchange, raising its market cap to $4.2 billion.
Read
Week In Review: Nanjing King-Friend Invests $95 Million In US Partner, Meitheal Pharma
Nanjing King-Friend Bio invested $95 million in Meitheal Pharma of Chicago, a generic injectables company, raising its holdings to a majority stake.
Read

STOCKS I FOLLOW

AXN Aoxing Pharmaceutical Company, Inc.
CRPNF China Pioneer Pharma Holdings Ltd.
CYIG CHINA YCT INTL GROUP
HCM Hutchison Chi-Med
ICLR Icon PLC
MCRPF MICROPORT SCIENTIFIC
MDCO The Medicines Company
MR Mindray Medical International Limited
NBY NovaBay Pharmaceuticals, Inc.
SCLN SciClone Pharmaceuticals, Inc.
WX WuXi PharmaTech Inc.
Load More

TWEETS

LATEST ACTIVITY

ChinaBio® Today
Week In Review: CanSino Nears $1 Billion Valuation Following Hong Kong IPO $AZN $AZN $MDT $ORMP https://t.co/xc1Unlv7ZV less
ChinaBio® Today
Week In Review: Tianjin CanSino Staging $160.5 Million Hong Kong IPO $MRK https://t.co/NakRBJr5rc...

ChinaBio® Today
Week In Review: Grifols Pays $1.9 Billion For 26% Stake In Shanghai RAAS $CASI $CASI $BGNE $GRFS $NVO https://t.co/rf0rbGpcBR less
All Posts

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications